HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Bone tumor

Bone tumors are abnormal growths of cells within the bone structure. These tumors can be either benign or malignant, with the potential to disrupt normal bone function. The development of a bone tumor may stem from various factors, including genetic mutations, environmental influences, or pre-existing conditions. Benign bone tumors are generally non-cancerous and tend to grow slowly. While they may not spread to other parts of the body, they can still cause complications by interfering with nearby tissues or causing fractures. Common examples of benign bone tumors include osteochondromas and osteoid osteomas.On the other hand, malignant bone tumors, such as osteosarcoma or Ewing sarcoma, are cancerous and have the potential to metastasize to other parts of the body. Malignant bone tumors often require prompt and comprehensive medical intervention, involving treatments like surgery, chemotherapy, and radiation therapy. Symptoms of a bone tumor may include pain, swelling, and restricted mobility in the affected area. Diagnosing a bone tumor typically involves imaging studies like X-rays, CT scans, or MRIs, as well as biopsy procedures to analyze the nature of the tumor cells.
Treatment plans for bone tumors are tailored to the specific type, location, and extent of the tumor. The goal is to eliminate the tumor while preserving as much healthy bone and function as possible. This may involve surgical removal, chemotherapy, radiation therapy, or a combination of these approaches.Regular follow-up and monitoring are crucial, especially after treatment, to detect any signs of recurrence or complications. Early detection and intervention play a vital role in improving outcomes and enhancing the quality of life for individuals affected by bone tumors. It is essential for individuals experiencing symptoms or at risk for bone tumors to consult with healthcare professionals for a thorough evaluation and appropriate management.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp